Dimethylaminoparthenolide-mediated inhibition of NF-κB decreases resistance to ADT by targeting AR variants in lethal prostate cancer

被引：0
|
作者：
Morel, Katherine L. [1 ]
Hamid, Anis A. [1 ]
Ellis, Leigh [1 ]
Sweeney, Christopher J. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2019年 / 18卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-19-B038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B038
引用
收藏
页数：2
相关论文
共 50 条
  • [1] NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants
    Morel, Katherine L.
    Hamid, Anis A.
    Clohessy, John G.
    Pandell, Nicole
    Ellis, Leigh
    Sweeney, Christopher J.
    MOLECULAR CANCER RESEARCH, 2021, 19 (07) : 1137 - 1145
  • [2] Inhibition of NF-κB decreases androgen receptor expression and prostate cancer growth
    Zhang, Liying
    Altuwaijri, Saleh
    Chang, Chawnshang
    Chen, Lishi
    Lal, Priti
    Korets, Ruslan
    Lilja, Hans
    Gerald, William L.
    CANCER RESEARCH, 2006, 66 (08)
  • [3] Adenovirus-mediated inhibition of NF-κB confers chemosensitization and apoptosis in prostate cancer cells
    Flynn, V
    Ramanitharan, A
    Moparty, K
    Davis, R
    Sikka, S
    Agrawal, KC
    Abdel-Mageed, AB
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (02) : 317 - 323
  • [4] Targeting the NF-κB Pathway in Prostate Cancer: A Promising Therapeutic Approach?
    Verzella, Daniela
    Fischietti, Mariafausta
    Capece, Daria
    Vecchiotti, Davide
    Del Vecchio, Filippo
    Cicciarelli, Germana
    Mastroiaco, Valentina
    Tessitore, Alessandra
    Alesse, Edoardo
    Zazzeroni, Francesca
    CURRENT DRUG TARGETS, 2016, 17 (03) : 311 - 320
  • [5] IKKβ inhibition modulates NF-κB signaling and decreases aggressiveness of ovarian cancer
    Hernandez, Lidia
    Hsu, Sarah
    Davidson, Ben
    Birrer, Michael J.
    Kohn, Elise C.
    Annunziata, Christina M.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [6] Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF-κB pathway (Review)
    Wang, Xiumei
    Fang, Yao
    Sun, Wenbo
    Xu, Zhi
    Zhang, Yanyan
    Wei, Xiaowei
    Ding, Xuansheng
    Xu, Yong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (05) : 1064 - 1074
  • [7] Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells
    Esparza-Lopez, Jose
    Longoria, Ossian
    de la Cruz-Escobar, Eliseo Neftali
    Cesar Garibay-Diaz, Julio
    Leon-Rodriguez, Eucario
    De Jesus Ibarra-Sanchez, Maria
    ONCOLOGY LETTERS, 2022, 23 (02)
  • [8] miR-30e*is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and chemotherapeutic resistance
    Egan, Shawn M.
    Gollnick, Sandra O.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [9] ERβ regulation of NF-κB activation in prostate cancer is mediated by HIF-1
    Mak, Paul
    Li, Jiarong
    Samanta, Sanjoy
    Mercurio, Arthur M.
    ONCOTARGET, 2015, 6 (37) : 40247 - 40254
  • [10] AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production
    Tahsin, Shekha
    Sane, Neha S.
    Cernyar, Brent
    Jiang, Linan
    Zohar, Yitshak
    Lee, Benjamin R.
    Miranti, Cindy K.
    ONCOGENE, 2024, 43 (27) : 2092 - 2103
12345